MODTYLSO Trademark

Trademark Overview

On Wednesday, July 8, 2020, a trademark application was filed for MODTYLSO with the United States Patent and Trademark Office. The USPTO has given the MODTYLSO trademark a serial number of 90042297. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 21, 2023. This trademark is owned by Idera Pharmaceuticals, Inc.. The MODTYLSO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of advanced metastatic melanoma
modtylso

General Information

Serial Number90042297
Word MarkMODTYLSO
Filing DateWednesday, July 8, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 21, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 24, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of advanced metastatic melanoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, August 4, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameIdera Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressExton, PA 19341
Party NameIdera Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressExton, PA 19341

Trademark Events

Event DateEvent Description
Monday, August 21, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 21, 2023ABANDONMENT - NO USE STATEMENT FILED
Saturday, January 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 19, 2023SOU EXTENSION 4 GRANTED
Thursday, January 19, 2023SOU EXTENSION 4 FILED
Thursday, January 19, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 20, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 18, 2022SOU EXTENSION 3 GRANTED
Monday, July 18, 2022SOU EXTENSION 3 FILED
Monday, July 18, 2022SOU TEAS EXTENSION RECEIVED
Friday, January 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 19, 2022SOU EXTENSION 2 GRANTED
Wednesday, January 19, 2022SOU EXTENSION 2 FILED
Wednesday, January 19, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 14, 2021SOU EXTENSION 1 GRANTED
Wednesday, July 14, 2021SOU EXTENSION 1 FILED
Wednesday, July 14, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, January 19, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 24, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 24, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 4, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, October 19, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, October 16, 2020ASSIGNED TO EXAMINER
Tuesday, August 4, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, July 11, 2020NEW APPLICATION ENTERED

Related Keywords

modtylso metastatic melanoma advanced treatment preparations pharmaceutical